- AMU
- Aix-Marseille Universitet
- Balance sheet total
- Total sum of the company's assets, or alternatively the sum of the debt and the equity
- Formulation
- The format of the vaccine, for example injectable liquid or powder
- CAPEX
- Capital expenditures
- Equity per share
- Equity divided by the number of shares at the end of the period
- Fill and finish
- The last step in the vaccine manufacturing process
- Freeze drying
- Also called lyophilization, to dry products based on the physical sublimation principle, which means that water goes directly from solid form to gaseous form under vacuum
- Intravenous
- Injectable drugs
- Cash flow per share
- The cash flow divided with the average number of shares during the period
- KeyPlant
- Swedish company the builds production facilities for the pharma industry
- LaminarPace
- Ziccum's patented technology that can air dry vaccines into a temperature-stable powder vaccine
- Micronized
- Finely ground powder
- OPEX
- Operational expenditures
- Employee stock option
- The right that in the future buy shares to a predetermined price
- Result per share before and after dilution
- Result divided by number of shares at the end of the period (dilution effects are not recalculated in the event of a negative result)
- Semi-continuous process
- Process where new substrate is added at regular intervals and residual product is taken out without being replaced
- Spin-out
- Part of a company is made into a new independent company
- Synthetic options
- Option that does not give the right to a share but instead cash compensation
- Tech transfer
- Moving technology from one organization to another
- Warrant
- A security that gives the holder the right to buy a newly issued share at a certain price for a certain period
- Topical
- A drug that is applied topically is given on body surfaces such as skin or mucous membranes
- US National Institute of Standards and Technology (NIST)
- Organisation that is driven by U.S. Department of Commerce
- Vaccine platform
- Different types of vaccine technologies e.g. mRNA, DNA, live attenuated virus, inactivated virus, viral vectors, adenavirus or protein-based vaccine
- Vaporize
- When liquid or a solid changes to gaseous form
- Lyophilization
- Freeze drying